Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.

Abstract

This case illustrates the acquisition of Ausimont, one of the world leaders in the speciality polymers industry, by Solvay Group, a blue chip Belgian multinational operating in the chemical and pharmaceutical industry, and outlines risks and opportunities related to the integration processes. Will Solvay Group manage to enhance the value creation for the acquired company? Will the acquired company manage to benefit from the parenting advantage arising from the acquisition? Is there a strategic fit between the two companies? Are there value-destruction risks in the post-merger integration process? What are the strategy implementation difficulties?
Location:
Industry:
Size:
EUR600 million sales
Other setting(s):
2000-2003

About

Abstract

This case illustrates the acquisition of Ausimont, one of the world leaders in the speciality polymers industry, by Solvay Group, a blue chip Belgian multinational operating in the chemical and pharmaceutical industry, and outlines risks and opportunities related to the integration processes. Will Solvay Group manage to enhance the value creation for the acquired company? Will the acquired company manage to benefit from the parenting advantage arising from the acquisition? Is there a strategic fit between the two companies? Are there value-destruction risks in the post-merger integration process? What are the strategy implementation difficulties?

Settings

Location:
Industry:
Size:
EUR600 million sales
Other setting(s):
2000-2003

Related